Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms

ObjectiveTo explore the value of testing methylated SDC2 (SDC2) in stool DNA combined with fecal immunochemical test (FIT) and serum tumor markers (TM) for the early detection of colorectal neoplasms.MethodsA total of 533 patients, including 150 with CRC (67 with early-stage CRC), 23 with APL, 85 wi...

Full description

Bibliographic Details
Main Authors: Tao Zeng, Zhongchao Huang, Xufa Yu, Li Zheng, Tao Liu, Boyu Tian, Siyu Xiao, Jiahui Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
SDC2
fecal immunochemical test
colorectal neoplasms
tumor markers
combined testing
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1166796/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1166796/full

Similar Items